Persistence of ivermectin in plasma and faeces following administration of a sustained-release bolus to cattle

被引:61
作者
Alvinerie, M
Sutra, JF
Galtier, P
Lifschitz, A
Virkel, G
Sallovitz, J
Lanusse, C
机构
[1] INRA, Lab Pharmacol & Toxicol, F-31931 Toulouse, France
[2] Univ Nacl Ctr, Fac Ciencias Vet, Area Farmacol, RA-7000 Tandil, Argentina
关键词
D O I
10.1053/rvsc.1998.0240
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Six calves (weight 210 to 230 kg) were dosed with an intra-ruminal slow-release bolus prepared to deliver ivermectin at a low daily dosage for 135 days. Ivermectin concentrations in jugular blood 160 days post-treatment were determined by high performance liquid chromatography (HPLC) using fluorescence detection. Ivermectin plasma concentrations increased gradually to achieve the steady-state concentration (20 ng ml(-1)) at approximately four days post-treatment, which was maintained for 120 days. The ivermectin peak plasma concentration (28.5 ng ml(-1)) was attained at 15 days post-administration of the bolus. The faecal ivermectin concentration rose to a maximal concentration of 4.1 mu g g(-1) at four days post-treatment, dropping to a steady-state concentration of around 1.18 mu g g(-1) which was maintained up to 120 days post-treatment. Ivermectin was detected in both plasma (0.05 ng ml(-1)) and faeces (2.67 ng g(-1)) up to 160 days. The high levels of ivermectin recovered in faeces indicate that a large proportion of the dose released by the bolus (80 to 90 per cent) is excreted in faeces.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 19 条
[1]   DETERMINATION OF MOXIDECTIN IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH AUTOMATED SOLID-PHASE EXTRACTION AND FLUORESCENCE DETECTION [J].
ALVINERIE, M ;
SUTRA, JF ;
BADRI, M ;
GALTIER, P .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (01) :119-124
[2]   Introduction: A symposium and dialogue on renal osteodystrophy [J].
Andress, DL .
SEMINARS IN DIALYSIS, 1996, 9 (04) :295-295
[3]   Lack of effect of ivermectin on antipyrine and erythromycin disposition in calves [J].
Bohlen, DM ;
Burrows, GE ;
Clarke, CR ;
Burrows, SL .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1995, 18 (06) :476-478
[4]  
Gibaldi M., 1982, PHARMACOKINETICS, P45
[5]  
Gover J, 1996, ENTOMOL EXP APPL, V81, P133, DOI 10.1007/BF00192138
[6]   ENDECTOCIDAL DRUGS - ECOLOGICAL RISKS AND COUNTERMEASURES [J].
HERD, R .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1995, 25 (08) :875-885
[7]   Persistence of ivermectin in plasma and faeces following treatment of cows with ivermectin sustained-release, pour-on or injectable formulations [J].
Herd, RP ;
Sams, RA ;
Ashcraft, SM .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1996, 26 (10) :1087-1093
[8]   Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle [J].
Lanusse, C ;
Lifschitz, A ;
Virkel, G ;
Alvarez, L ;
Sanchez, S ;
Sutra, JF ;
Galtier, P ;
Alvinerie, M .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (02) :91-99
[9]   FIELD EFFECTS OF IVERMECTIN RESIDUES ON DUNG BEETLES [J].
LUMARET, JP ;
GALANTE, E ;
LUMBRERAS, C ;
MENA, J ;
BERTRAND, M ;
BERNAL, JL ;
COOPER, JF ;
KADIRI, N ;
CROWE, D .
JOURNAL OF APPLIED ECOLOGY, 1993, 30 (03) :428-436
[10]   Ecotoxicology and residues of anthelmintic compounds [J].
McKellar, QA .
VETERINARY PARASITOLOGY, 1997, 72 (3-4) :413-426